{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:11:41Z","timestamp":1777597901704,"version":"3.51.4"},"reference-count":44,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2020.0119","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T09:41:17Z","timestamp":1581586877000},"source":"Crossref","is-referenced-by-count":15,"title":["Disorders Caused by Genetic Mosaicism"],"prefix":"10.3238","author":[{"given":"Ute","family":"Moog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Felbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Has","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Zirn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"10.3238\/arztebl.2020.0119_ref1","doi-asserted-by":"crossref","unstructured":"Clarke CM, Edwards JH, Smallpeice V: 21-trisomy\/normal mosaicism in an intelligent child with some mongoloid characters. Lancet 1961; 1: 1028\u201330","DOI":"10.1016\/S0140-6736(61)91833-5"},{"key":"10.3238\/arztebl.2020.0119_ref2","doi-asserted-by":"crossref","unstructured":"Rohlin A, Wernersson J, Engwall Y, Wiklund L, Bj\u00f6rk J, Nordling M: Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat 2009; 30: 1012\u201320","DOI":"10.1002\/humu.20980"},{"key":"10.3238\/arztebl.2020.0119_ref3","doi-asserted-by":"crossref","unstructured":"Lim YH, Moscato Z, Choate KA: Mosaicism in cutaneous disorders. Annu Rev Genet 2017; 51: 123\u201341","DOI":"10.1146\/annurev-genet-121415-121955"},{"key":"10.3238\/arztebl.2020.0119_ref4","doi-asserted-by":"crossref","unstructured":"Happle R: The categories of cutaneous mosaicism: a proposed classification. Am J Med Genet A 2016; 170A: 452\u20139","DOI":"10.1002\/ajmg.a.37439"},{"key":"10.3238\/arztebl.2020.0119_ref5","doi-asserted-by":"crossref","unstructured":"Hafner C, Groesser L: Mosaic RASopathies. Cell Cycle 2013; 12: 43\u201350","DOI":"10.4161\/cc.23108"},{"key":"10.3238\/arztebl.2020.0119_ref6","doi-asserted-by":"crossref","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VE, et al.: PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015; 167A: 287\u201395","DOI":"10.1002\/ajmg.a.36836"},{"key":"10.3238\/arztebl.2020.0119_ref7","doi-asserted-by":"crossref","unstructured":"Nathan N, Keppler-Noreuil KM, Biesecker LG, Moss J, Darling TN: Mosaic disorders of the PI3K\/PTEN\/AKT\/TSC\/mTORC1 signaling pathway. Dermatol Clin 2017; 35: 51\u201360","DOI":"10.1016\/j.det.2016.07.001"},{"key":"10.3238\/arztebl.2020.0119_ref8","doi-asserted-by":"crossref","unstructured":"D\u2018Gama AM, Walsh CA: Somatic mosaicism and neurodevelopmental disease. Nat Neurosci 2018; 21: 1504\u201314","DOI":"10.1038\/s41593-018-0257-3"},{"key":"10.3238\/arztebl.2020.0119_ref9","doi-asserted-by":"crossref","unstructured":"Bae T, Tomasini L, Mariani J, et al.: Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis. Science 2018; 359: 550\u20135","DOI":"10.1126\/science.aan8690"},{"key":"10.3238\/arztebl.2020.0119_ref10","doi-asserted-by":"crossref","unstructured":"Groesser L, Herschberger E, Ruetten A, et al.: Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet 2012; 44: 783\u20137","DOI":"10.1038\/ng.2316"},{"key":"10.3238\/arztebl.2020.0119_ref11","doi-asserted-by":"crossref","unstructured":"Happle R: Wie h\u00e4ufig sind genetische Mosaike in der Haut? Hautarzt 2014; 65: 536\u201341","DOI":"10.1007\/s00105-013-2716-9"},{"key":"10.3238\/arztebl.2020.0119_ref12","doi-asserted-by":"crossref","unstructured":"Has C, K\u00f6nig A: Rudolf Happle zum 80. Geburtstag. Hautarzt 2018; 69: 343\u20136","DOI":"10.1007\/s00105-018-4148-z"},{"key":"10.3238\/arztebl.2020.0119_ref13","doi-asserted-by":"crossref","unstructured":"Cal\u00ec F, Chiavetta V, Ruggeri G, et al.: Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM\u2122 platform. Eur J Med Genet 2017; 60: 93\u20139","DOI":"10.1016\/j.ejmg.2016.11.001"},{"key":"10.3238\/arztebl.2020.0119_ref14","doi-asserted-by":"crossref","unstructured":"Peron A, Au KS, Northrup H: Genetics, genomics, and genotype-phenotype correlations of TSC: insights for clinical practice. Am J Med Genet C Semin Med Genet 2018; 178: 281\u201390","DOI":"10.1002\/ajmg.c.31651"},{"key":"10.3238\/arztebl.2020.0119_ref15","doi-asserted-by":"crossref","unstructured":"Borrie SC, Brems H, Legius E, Bagni C: Cognitive dysfunctions in intellectual disabilities: the contributions of the Ras-MAPK and PI3K-AKT-mTOR pathways. Annu Rev Genomics Hum Genet 2017; 18: 115\u201342","DOI":"10.1146\/annurev-genom-091416-035332"},{"key":"10.3238\/arztebl.2020.0119_ref16","doi-asserted-by":"crossref","unstructured":"Rivi\u00e8re JB, Mirzaa GM, O\u2018Roak BJ, et al.: De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 2012; 44: 934\u201340","DOI":"10.1038\/ng.2331"},{"key":"10.3238\/arztebl.2020.0119_ref17","doi-asserted-by":"crossref","unstructured":"Mirzaa G, Timms AE, Conti V, et al.: PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight 2016; 1: pii: 87623","DOI":"10.1172\/jci.insight.87623"},{"key":"10.3238\/arztebl.2020.0119_ref18","doi-asserted-by":"crossref","unstructured":"Lindhurst MJ, Sapp JC, Teer JK, et al.: A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365: 611\u20139","DOI":"10.1056\/NEJMoa1104017"},{"key":"10.3238\/arztebl.2020.0119_ref19","doi-asserted-by":"crossref","unstructured":"Juric-Sekhar G, Hevner RF: Malformations of cerebral cortex development: molecules and mechanisms. Annu Rev Pathol 2019; 14: 293\u2013318","DOI":"10.1146\/annurev-pathmechdis-012418-012927"},{"key":"10.3238\/arztebl.2020.0119_ref20","doi-asserted-by":"crossref","unstructured":"Marsan E, Baulac S: Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 2018; 44: 6\u201317","DOI":"10.1111\/nan.12463"},{"key":"10.3238\/arztebl.2020.0119_ref21","doi-asserted-by":"crossref","unstructured":"Baldassari S, Ribierre T, Marsan E, et al.: Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol 2019; 138: 885\u2013900","DOI":"10.1007\/s00401-019-02061-5"},{"key":"10.3238\/arztebl.2020.0119_ref22","doi-asserted-by":"crossref","unstructured":"Zenker M, Kutsche K: RASopathien. medgen 2016; 28: 15","DOI":"10.1007\/s11825-016-0080-8"},{"key":"10.3238\/arztebl.2020.0119_ref23","doi-asserted-by":"crossref","unstructured":"Li S, Balmain A, Counter CM: A model for RAS mutation patterns in cancers: finding the sweet spot. Nat Rev Cancer 2018; 18: 767\u201377","DOI":"10.1038\/s41568-018-0076-6"},{"key":"10.3238\/arztebl.2020.0119_ref24","doi-asserted-by":"crossref","unstructured":"Alikhan A, Ibrahimi OA, Eisen DB: Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. J Am Acad Dermatol 2012; 67: 495. e1\u201317; quiz 512\u20134","DOI":"10.1016\/j.jaad.2012.06.023"},{"key":"10.3238\/arztebl.2020.0119_ref25","doi-asserted-by":"crossref","unstructured":"Kinsler VA, Boccara O, Fraitag S, Torrelo A, Vabres P, Diociauti A: Mosaic abnormalities of the skin\u2014review and guidelines from the European Reference Network for rare skin diseases (ERN-Skin). Br J Dermatol 2019; doi: 10.1111\/bjd.17924 [Epub ahead of print]","DOI":"10.1111\/bjd.17924"},{"key":"10.3238\/arztebl.2020.0119_ref26","doi-asserted-by":"crossref","unstructured":"Wang SM, Hsieh YJ, Chang KM, Tsai HL, Chen CP: Schimmelpenning syndrome: a case report and literature review. Pediatr Neonatol 2014; 55: 487\u201390","DOI":"10.1016\/j.pedneo.2012.12.017"},{"key":"10.3238\/arztebl.2020.0119_ref27","doi-asserted-by":"crossref","unstructured":"Ardinger HH, Horii KA, Begleiter ML: Expanding the phenotype of oculoectodermal syndrome: possible relationship to encephalocraniocutaneous lipomatosis. Am J Med Genet A 2007; 143A: 2959\u201362","DOI":"10.1002\/ajmg.a.31969"},{"key":"10.3238\/arztebl.2020.0119_ref28","doi-asserted-by":"crossref","unstructured":"Boppudi S, B\u00f6gershausen N, Hove HB, et al.: Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. Clin Genet 2016; 90: 334\u201342","DOI":"10.1111\/cge.12775"},{"key":"10.3238\/arztebl.2020.0119_ref29","doi-asserted-by":"crossref","unstructured":"Moog U: Encephalocraniocutaneous lipomatosis. J Med Genet 2009; 46: 721\u20139","DOI":"10.1136\/jmg.2009.066068"},{"key":"10.3238\/arztebl.2020.0119_ref30","doi-asserted-by":"crossref","unstructured":"Bennett JT, Tan TY, Alcantara D, et al.: Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis. Am J Hum Genet 2016; 98: 579\u201387","DOI":"10.1016\/j.ajhg.2016.02.006"},{"key":"10.3238\/arztebl.2020.0119_ref31","doi-asserted-by":"crossref","unstructured":"Valera ET, McConechy MK, Gayden T, et al.: Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas. Acta Neuropathol 2018; 136: 657\u201360","DOI":"10.1007\/s00401-018-1898-8"},{"key":"10.3238\/arztebl.2020.0119_ref32","doi-asserted-by":"crossref","unstructured":"Shirley MD, Tang H, Gallione CJ, et al.: Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013; 368: 1971\u20139","DOI":"10.1056\/NEJMoa1213507"},{"key":"10.3238\/arztebl.2020.0119_ref33","doi-asserted-by":"crossref","unstructured":"Al-Olabi L, Polubothu S, Dowsett K, et al.: Mosaic RAS\/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest 2018; 128: 1496\u2013508","DOI":"10.1172\/JCI98589"},{"key":"10.3238\/arztebl.2020.0119_ref34","doi-asserted-by":"crossref","unstructured":"Eerola I, Boon LM, Mulliken JB, et al.: Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003; 73: 1240\u20139","DOI":"10.1086\/379793"},{"key":"10.3238\/arztebl.2020.0119_ref35","doi-asserted-by":"crossref","unstructured":"Qin L, Wang J, Tian X, et al.: Detection and quantification of mosaic mutations in disease genes by next-generation sequencing. J Mol Diagn 2016; 18: 446\u201353","DOI":"10.1016\/j.jmoldx.2016.01.002"},{"key":"10.3238\/arztebl.2020.0119_ref36","doi-asserted-by":"crossref","unstructured":"Keppler-Noreuil KM, Parker VE, Darling TN, Martinez-Agosto JA: Somatic overgrowth disorders of the PI3K\/AKT\/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet 2016; 172: 402\u201321","DOI":"10.1002\/ajmg.c.31531"},{"key":"10.3238\/arztebl.2020.0119_ref37","doi-asserted-by":"crossref","unstructured":"Venot Q, Blanc T, Rabia SH, et al.: Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 2018; 558: 540\u20136","DOI":"10.1038\/s41586-018-0217-9"},{"key":"10.3238\/arztebl.2020.0119_ref38","doi-asserted-by":"crossref","unstructured":"Leoni C, Gullo G, Resta N, et al.: First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma. Am J Med Genet A 2019; 179: 1319\u201324","DOI":"10.1002\/ajmg.a.61160"},{"key":"10.3238\/arztebl.2020.0119_ref39","doi-asserted-by":"crossref","unstructured":"Rouill\u00e9 T, Aractingi S, Kadlub N, et al.: Local inhibition of MEK\/Akt prevents cellular growth in human congenital melanocytic nevi. J Invest Dermatol 2019; 139: 2004\u201315. e13","DOI":"10.1016\/j.jid.2019.03.1156"},{"key":"10.3238\/arztebl.2020.0119_ref40","doi-asserted-by":"crossref","unstructured":"Stosser MB, Lindy AS, Butler E, et al.: High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders. Genet Med 2018; 20: 403\u201310","DOI":"10.1038\/gim.2017.114"},{"key":"10.3238\/arztebl.2020.0119_ref41","unstructured":"Happle R: Kutane Mosaike: Muster und molekulare Mechanismen. Dtsch Arztebl 2004; 101: A-1886"},{"key":"10.3238\/arztebl.2020.0119_ref42","doi-asserted-by":"crossref","unstructured":"Happle R: Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol 1993; 129: 1460\u201370","DOI":"10.1001\/archderm.129.11.1460"},{"key":"10.3238\/arztebl.2020.0119_ref43","unstructured":"Mirzaa G, Conway R, Graham JM Jr, et al.: PIK3CA-Related Segmental Overgrowth. In: Adam MP, Ardinger HH, Pagon RA, et al., (eds.): GeneReviews. Seattle (WA): University of Washington 2013; www.ncbi.nlm.nih.gov\/books\/NBK153722\/ (last accessed on 28 January 2020)."},{"key":"10.3238\/arztebl.2020.0119_ref44","doi-asserted-by":"crossref","unstructured":"Jamuar SS, Lam AT, Kircher M, et al.: Somatic mutations in cerebral cortical malformations. N Engl J Med 2014; 371: 733\u201343","DOI":"10.1056\/NEJMoa1314432"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2020.0119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:50:48Z","timestamp":1638784248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2020.0119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2020.0119","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}